Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Severe outcomes of COVID-19 among patients with COPD and asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The influence of active and passive air humidification on exhaled breath condensate volume

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Developing and validating COVID-19 adverse outcome risk prediction models from a bi-national European cohort of 5594 patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. How patients in Denmark acquire their medicines: overview, data sources and implications for pharmacoepidemiology

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Severe outcomes of COVID-19 among patients with COPD and asthma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Ciclosporin

    Publikation: Bog/antologi/afhandling/rapportRapportRådgivning

  5. The Adaptive COVID-19 Treatment Trial-1 (ACTT-1) in a real-world population: a comparative observational study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Recent research suggests that women with polycystic ovary syndrome (PCOS) have a higher risk of asthma. However, the severity of asthma, use of antiasthma medication and effect on fertility have yet to be investigated. In a case-control cross-sectional registry study using the Danish National Patient Register and other Danish registries, asthma prevalence, asthma severity, antiasthma medication use and fertility outcome were investigated among two groups of women with PCOS (n=1358 and n=17 123) and a healthy control group (n=5340). Both asthma prevalence (OR 1.45, 95% CI 1.24-1.70) and mean daily inhaled corticosteroid dose were higher among women with PCOS compared with healthy controls, whereas asthma severity was the same in women with and without PCOS. Women with PCOS and asthma had more in vitro fertilisation treatments than women in the control group with asthma, but the numbers of children per woman and spontaneous abortions were the same. Women with PCOS have a higher prevalence of asthma and a higher use of inhaled corticosteroids, whereas asthma severity is the same in women with and without PCOS. Asthma is associated with more in vitro fertilisation treatments in women with PCOS.

OriginalsprogEngelsk
TidsskriftERJ Open Research
Vol/bind4
Udgave nummer4
ISSN2312-0541
DOI
StatusUdgivet - okt. 2018

ID: 55605220